ESMO 2024: Exact Sciences unveils results from cancer algorithm trial
The results now are set to go alongside the company’s BLUE-C trial as part of an FDA submission for the cancer detecting algorithm.
The results now are set to go alongside the company’s BLUE-C trial as part of an FDA submission for the cancer detecting algorithm.
The FDA has cleared the company’s SmartPatch for measuring multiple health metrics including haemoglobin and potassium levels, in patients undergoing dialysis.
The medical devices industry continues to be a hotbed of patent innovation. Activity is driven by increased need for homecare,...
Firefly and Zeto team up to distribute EEG headset devices
AstraZeneca eyes up transition to eco-friendly inhaler propellant
Apple to add sleep apnoea notification to Series 10 watch
Exer AI and Mayo Clinic unite to treat hand and wrist disorders using AI